ArticleAdvanced healthcare materials2025
Guided Bone Regeneration Membrane Materials Loaded with Chimeric Nanovesicles Promote Early Bone Defect Regeneration.
Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Design and applications of barrier membranes for guided bone regeneration.Bioactive materials · 2026Review
- Tannic acid-assisted mechanical training transforms natural hydrogels into robust and bioactive membranes for guided bone regeneration.Materials today. Bio · 2026Article
- Piezoelectric Heterojunction-driven Biomedical Revolution: From Construction Principles to Diagnostic and Therapeutic Applications.Theranostics · 2026Review
- Guided Bone Regeneration Membrane Materials Loaded with Chimeric Nanovesicles Promote Early Bone Defect Regeneration.Advanced healthcare materials · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Early bone defect regeneration remains a major clinical challenge owing to a compromised osteogenic microenvironment characterized by insufficient mineralization and immature collagen deposition, which severely impede mechanical stability. Although conventional guided bone regeneration (GBR) membranes provide passive barrier functions, their lack of dynamic immune response regulation often leads to delayed ossification. To address this critical gap, a plasma-treated polycaprolactone (PT-PCL) electrospun nanofiber membrane functionalized with ultrasound sequentially extruded stromal vascular fraction chimeric vesicles (USE-SCNVs) is developed. The ultrasound-sequential extrusion approach requires less equipment, is faster, and holds greater potential for clinical application than traditional extrusion methods. Compared with nanovesicles formed by simple adipose-derived stem cells, these nanovesicles are more efficiently internalized by macrophages and are enriched with miRNAs, s uch as miR-30b, which promote rapid M2 macrophage polarization. In vivo experiments demonstrated that the nanofiber membranes loaded with USE-SCNVs can promote the rapid formation and maturation of new bone in the bone defect area within 2 weeks, forming primarily mature bone with increased platelet-like bone density.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.